Literature DB >> 18316821

Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.

John D Perry1, Larissa Laine, Susan Hughes, Audrey Nicholson, Angela Galloway, F Kate Gould.   

Abstract

OBJECTIVES: To assess the utility of direct plating of whole sputa onto selective media as a means of identifying antimicrobial resistance in strains of Pseudomonas aeruginosa from the sputa of patients with cystic fibrosis (CF).
METHODS: A total of 45 sputum samples from CF patients were cultured onto conventional culture media for isolation of P. aeruginosa and were also cultured directly onto Iso-Sensitest agar plates containing each of 10 antimicrobials incorporated at a 'breakpoint' concentration. A representative of each colonial type (morphotype) recovered from both routine media and selective media was tested for its susceptibility to 10 antimicrobials using a standard agar dilution MIC technique.
RESULTS: Of the samples shown to contain resistant strains, the proportion (%) detected using routine media and selective media, respectively, was: 42 and 100 for amikacin, 57 and 100 for gentamicin, 54 and 100 for tobramycin, 88 and 77 for aztreonam, 62 and 90 for ceftazidime, 70 and 97 for meropenem, 61 and 100 for piperacillin/tazobactam, 90 and 86 for temocillin, 66 and 100 for ticarcillin/clavulanic acid, and 80 and 90 for ciprofloxacin resistance. The increased rates of isolation on selective media were statistically significant (P < 0.05) for amikacin, gentamicin, tobramycin, meropenem, piperacillin/tazobactam and ticarcillin/clavulanic acid.
CONCLUSIONS: For most antimicrobials, selection of colonies from conventional media for antimicrobial susceptibility testing provided a considerable underestimation of resistance in P. aeruginosa. The use of selective media for the culture of whole sputum was effective for the detection of resistant isolates of P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316821     DOI: 10.1093/jac/dkn081

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  11 in total

Review 1.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

Review 2.  Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.

Authors:  Axel Dalhoff
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 3.  Aztreonam lysine for inhalation solution: in cystic fibrosis.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

4.  Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Authors:  Lucie Vettoretti; Patrick Plésiat; Cédric Muller; Farid El Garch; Gilles Phan; Inna Attrée; Arnaud Ducruix; Catherine Llanes
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

5.  Antimicrobial activity of different Lactobacillus species against multi- drug resistant clinical isolates of Pseudomonas aeruginosa.

Authors:  H Jamalifar; Hr Rahimi; N Samadi; Ar Shahverdi; Z Sharifian; F Hosseini; H Eslahi; Mr Fazeli
Journal:  Iran J Microbiol       Date:  2011-03

6.  A Selective, Dual Emission β-Alanine Aminopeptidase Activated Fluorescent Probe for the Detection of Pseudomonas aeruginosa, Burkholderia cepacia, and Serratia marcescens.

Authors:  Linda Váradi; Elias Y Najib; David E Hibbs; John D Perry; Paul W Groundwater
Journal:  Molecules       Date:  2019-09-30       Impact factor: 4.411

7.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14

8.  Targeted Antibiotic Prophylaxis for Lung Transplantation in Cystic Fibrosis Patients Colonised with Pseudomonas aeruginosa Using Multiple Combination Bactericidal Testing.

Authors:  Helmy Haja Mydin; Paul A Corris; Audrey Nicholson; John D Perry; Gerard Meachery; Emma C L Marrs; Steven Peart; Christine Fagan; James L Lordan; Andrew J Fisher; Frances K Gould
Journal:  J Transplant       Date:  2012-07-16

Review 9.  [Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis].

Authors:  Antonio Oliver; Teresa Alarcón; Estrella Caballero; Rafael Cantón
Journal:  Enferm Infecc Microbiol Clin       Date:  2009-02-20       Impact factor: 1.731

Review 10.  Recent advances in the microbiology of respiratory tract infection in cystic fibrosis.

Authors:  Juliet Foweraker
Journal:  Br Med Bull       Date:  2009-01-20       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.